Schonfeld Strategic Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.09M	Buy	260,626 +247,526	+1,890%	+$5.38M	0.04%	432
2025 Q4	$275K	Sell	13,100 -119,023	-90%	-$2.08M	﹤0.01%	1603
2025 Q3	$2.03M	Sell	132,123 -132,621	-50%	-$1.74M	0.01%	1022
2025 Q2	$2.48M	Buy	264,744 +218,349	+471%	+$2.4M	0.02%	865
2025 Q1	$570K	Buy	46,395 +25,738	+125%	+$363K	﹤0.01%	1528
2024 Q4	$273K	Sell	20,657 -166,806	-89%	-$2.85M	﹤0.01%	1648
2024 Q3	$3.61M	Sell	187,463 -73,413	-28%	-$1.52M	0.02%	650
2024 Q2	$5.36M	Sell	260,876 -524,768	-67%	-$11M	0.03%	525
2024 Q1	$18.7M	Buy	785,644 +314,169	+67%	+$7.01M	0.12%	186
2023 Q4	$10.2M	Buy	471,475 +253,062	+116%	+$3.89M	0.07%	350
2023 Q3	$3.17M	Sell	218,413 -20,154	-8%	-$381K	0.02%	680
2023 Q2	$4.99M	Buy	238,567 +91,001	+62%	+$1.89M	0.04%	489
2023 Q1	$3.12M	Buy	147,566 +138,466	+1,522%	+$3.44M	0.03%	574
2022 Q4	$232K	Buy	+9,100	New	+$212K	﹤0.01%	1919
2022 Q1	–	Sell	-12,300	Closed	-$269K	–	2900
2021 Q4	$269K	Sell	12,300 -63,300	-84%	-$1.17M	﹤0.01%	1557
2021 Q3	$1.45M	Sell	75,600 -43,801	-37%	-$730K	0.01%	825
2021 Q2	$2.05M	Sell	119,401 -5,101	-4%	-$93.4K	0.02%	703
2021 Q1	$2.78M	Sell	124,502 -32,628	-21%	-$737K	0.03%	587
2020 Q4	$3.5M	Buy	157,130 +136,314	+655%	+$2.83M	0.05%	479
2020 Q3	$307K	Buy	+20,816	New	+$317K	0.01%	1078